Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events

Autor: Marwa Bachir, Lorenzo Guglielmetti, Simone Tunesi, Typhaine Billard-Pomares, Sheila Chiesi, Jérémy Jaffré, Hugo Langris, Valérie Pourcher, Frédéric Schramm, Nadine Lemaître, Jérôme Robert, O. Bouchaud, T. Billard-Pomares, E. Carbonnelle, F. Mechaï, H. Nunes, M. Pellan, A.-S. Morin, C. Dumesnil, J. Dumoulin, A.-L. Roux, M. Jachym, D. le Du, D. Marigot-Outtandy, S. Abgrall, V. Chambrin, C. Guillet, B. Fantin, A. Galy, J.-W. Decousser, J.D. Lelièvre, S. Gallien, B. Nebbad-Lechani, L. Deconinck, S. Bulifon, N. Fortineau, B. Wyplosz, F. Cohen, N. Lemaitre, B. Crestani, N. Grall, C. Pierre-Audigier, C. Rioux, Y. Yazdanpanah, C. Le Jeunne, P. Morand, N. Roche, J. Pavie, P. Loulergue, V. Delcey, E. Lecorché, A.-L. Munier, F. Mougari, P. Sellier, E. Bille, A. Ferroni, R. Guéry, A. Hummel, J. Lourenco, A. Aubry, I. Bonnet, E. Caumes, C. Londner, F. Morel, K. Lacombe, V. Lalande, J.-L. Meynard, N. Veziris, N. De Castro, B. Denis, M. Lafaurie, J.-M. Molina, A. Canestri, L. Lassel, G. Pialoux, C. Verdet, A.-L. Nardi, M. Gominet, E. Catherinot

Publikováno v: International Journal of Infectious Diseases, Vol 107, Iss , Pp 86-91 (2021)

Objectives: Isoniazid-monoresistant tuberculosis (HR-TB) is the most prevalent form of drug-resistant TB worldwide and in France and is associated with poorer treatment outcomes compared with drug-susceptible TB (DS-TB). The objective of this study w

Externí odkaz: https://doaj.org/article/a4fbd531fe364aadb50ff12aceec42be

Isoniazid-monoresistant tuberculosis in France: Risk factors, treatment outcomes and adverse events

Autor: Nadine Lemaître, Jérôme Robert, N. Fortineau, C. Verdet, P. Morand, S. Gallien, O. Bouchaud, P. Sellier, K. Lacombe, Frédéric Schramm, A. Hummel, F. Mechaï, Valérie Pourcher, J.-L. Meynard, V. Delcey, J. Lourenco, J.-M. Molina, J.-W. Decousser, A. Ferroni, Christophe Rioux, T. Billard-Pomares, V. Lalande, B. Wyplosz, Dhiba Marigot-Outtandy, D. Le Dû, F. Cohen, G. Pialoux, C. Pierre-Audigier, H. Nunes, E. Catherinot, Lorenzo Guglielmetti, L. Lassel, B. Denis, M. Gominet, Nicolas Veziris, B. Crestani, V. Chambrin, Eric Caumes, L. Deconinck, R. Guéry, Yazdan Yazdanpanah, A.-L. Roux, C. Guillet, A.-L. Munier, B. Nebbad-Lechani, F. Morel, C. Le Jeunne, N. Grall, M. Lafaurie, Hugo Langris, E. Carbonnelle, E. Bille, N. Lemaitre, S. Abgrall, M. Pellan, Faiza Mougari, I. Bonnet, A.-S. Morin, P. Loulergue, Marwa Bachir, Sheila Chiesi, J. Jaffré, Alexandra Aubry, A.-L. Nardi, J. Dumoulin, S. Bulifon, C. Londner, N. Roche, M. Jachym, A. Canestri, J. Pavie, Simone Tunesi, A. Galy, N. De Castro, B. Fantin, J.D. Lelièvre, C. Dumesnil, Typhaine Billard-Pomares, E. Lecorché

Publikováno v: International Journal of Infectious Diseases
International Journal of Infectious Diseases, Elsevier, 2021, ⟨10.1016/j.ijid.2021.03.093⟩
International Journal of Infectious Diseases, Vol 107, Iss, Pp 86-91 (2021)
International Journal of Infectious Diseases, 2021, ⟨10.1016/j.ijid.2021.03.093⟩

Objectives Isoniazid-monoresistant tuberculosis (HR-TB) is the most prevalent form of drug-resistant TB worldwide and in France and is associated with poorer treatment outcomes compared with drug-susceptible TB (DS-TB). The objective of this study wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff14195da8822c1a58682876f3892dab
https://doi.org/10.1016/j.ijid.2021.03.093

Recurrence of brucellosis on breast implants

Autor: C. Estagnasié, L. Surgers, K. Berdugo, L. Monnier-Cholley, M. Schmidt, J.-L. Meynard, E. Gras

Publikováno v: Infectious Diseases Now. 53:104644

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc0f108fac95ce9a42e515111083998f
https://doi.org/10.1016/j.idnow.2023.01.004

Why are people still dying of drug-susceptible TB in Paris in the 21

Autor: A-L, Beaumont, A, Doumbia, N, Château, J-L, Meynard, J, Pacanowski, N, Valin, J, Cadranel, V, Lalande, C, Verdet, L, Lassel, G, Pialoux, O, Fain, M, Morgand, K, Lacombe, L, Surgers

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 26(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2a0cfcb757d903195c6cceb3169934fd
https://pubmed.ncbi.nlm.nih.gov/35505488

HIV Infection and Long-Term Residual Cardiovascular Risk After Acute Coronary Syndrome

Autor: Franck Boccara, Murielle Mary‐Krause, Valérie Potard, Emmanuel Teiger, Sylvie Lang, Nadjib Hammoudi, Marion Chauvet, Stéphane Ederhy, Laurie Dufour‐Soulat, Yann Ancedy, Pascal Nhan, Saroumadi Adavane, Ph. Gabriel Steg, Christian Funck‐Brentano, Dominique Costagliola, Ariel Cohen, S. Weber, K. Wahbi, P. Beaufils, P. Henri, G. Sideris, D. Thomas, G. Montalescot, F. Beygui, C. Meuleman, S. Janower, F. Raoux, G. Dufaitre, N. Benyounes, P. L. Michel, B. Petillon, N. Hammoudi, P. Gueret, J. L. Dubois‐Rande, E. Teiger, P. Lim, M. Slama, P. Colin, C. Saudubray, O. Dubourg, O. Milleron, B. Gallet, F. Duclos, S. Godard, L. Fuchs, V. Dormagen, P. Lewy, S. Cattan, O. Nallet, G. Grollier, J. Shayne, J. E. Wolf, Y. Cottin, J. Machecourt, H. Bouvaist, G. Finet, B. De Breyne, J. N. Trochu, M. Baudouy, E. Ferrari, M. Benhamou, J. Allal, D. Coisne, H. Le Breton, M. Bedossa, J. Puel, M. Elbaz, L. Larifla, S. Matheron, R. Landman, G. Fremont, G. Spiridon, P. Blanche, J. P. Morini, D. Sicard, V. Zeller, D. Batisse, P. Clevenbergh, G. Cessot, E. Dohin, M. A. Valantin, S. Khelifa, P. M. Girard, F. Lallemand, B. Lefebvre, J. P. Laporte, J. L. Meynard, H. Bideault, O. Picard, M. C. Meyohas, P. Campa, J. Tredup, L. Fonquernie, G. Raguin, J. M. Molina, A. Furco, S. Gharakanian, J. P. Vincensini, J. B. Guiard‐Schmid, G. Pialoux, B. Cardon, A. S. Lascaux, F. Chaix, P. Lesprit, R. Fior, F. Boue, C. Dupont, C. Bellier, A. Blanc, T. Lambert, T. Touahri, G. Force, P. de Truchis, M. A. Compagnucci‐Seguenot, I. Cahitte, L. Roudière, M. E. Techer, P. Thelpin, D. Troisvallets, A. Lepretre, M. Echard, Y. Le Mercier, D. Houlbert, S. Dargere, C. Bazin, R. Verdon, B. De Goer, M. Duong, P. Chavanet, E. Gozlan, P. Leclercq, F. Brunel‐Dal Mas, J. Durant, P. Heudier, C. Brunet‐François, G. Le Moal, J. M. Chapplin, C. Arvieux, G. Chaumentin, B. Guerin, E. Bonnet, Y. Poinsignon, F. Boulard, I. De Lacroix, M. T. Goerger‐Sow, M. Kirstetter, M. Volstein, F. Laylavoix, X. Copin, C. Ceppi

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association
Journal of the American Heart Association, Wiley-Blackwell, 2020, 9 (17), pp.e017578. ⟨10.1161/JAHA.119.017578⟩

Background It is unclear whether HIV infection affects the long‐term prognosis after an acute coronary syndrome (ACS). The objective of the current study was to compare rates of major adverse cardiac and cerebrovascular events after a first ACS bet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129c8d2e94dca17e310bb04f1d90ebc1
https://pubmed.ncbi.nlm.nih.gov/32844727